Christal Mickle
Fondatore presso ZEVRA THERAPEUTICS, INC.
Patrimonio netto: 652 636 $ in data 30/06/2024
Posizioni attive di Christal Mickle
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Corporate Officer/Principal | 10/10/2023 | - |
| Fondatore | 30/10/2006 | - | |
| Direttore/Membro del Consiglio | 30/10/2006 | 15/04/2015 | |
| Amministratore Delegato | 01/06/2023 | 10/10/2023 | |
| Direttore operativo | 30/10/2006 | 11/01/2023 | |
| Contatto Relazioni con gli Investitori | 30/10/2006 | - | |
| Public Communications Contact | 18/09/2009 | - | |
| Presidente | 01/06/2023 | 10/10/2023 | |
| Segretario Aziendale | 30/10/2006 | - | |
| Treasurer | 30/10/2006 | - |
Storia della carriera di Christal Mickle
Precedenti posizioni note di Christal Mickle
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01/01/2002 | 01/01/2005 |
Formazione di Christal Mickle
| University of Virginia | Graduate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
- Borsa valori
- Insiders
- Christal Mickle
- Esperienza
